HB 576 revises the funding for Medicaid and health and support services for children and adults who are aged, blind, or disabled. The bill allows a portion of the state's annual tobacco settlement proceeds to be used as matching funds for federal programs, including the Children's Health Insurance Program (CHIP), home visiting services, and specific Medicaid waivers. It also expands the uses of an existing state special revenue account, enabling its funds to similarly provide matching funds for these same services. These changes are designed to help secure federal funding for a range of health and support programs.
HB 794 revises general pharmacy laws, impacting pharmacies, pharmacy technicians, and clinical pharmacist practitioners. The bill updates and clarifies definitions, removes the utilization plan requirement for in-state and mail-order pharmacies, and mandates an endorsement for clinical pharmacist practitioners. It also eliminates outdated notification practices for biosimilar drug selection and generic drug signage requirements. Additionally, the bill clarifies pharmacy wholesale distribution licenses and the powers of the Board of Pharmacy, and adjusts provisions for insurance plans regarding out-of-state mail-order pharmacies.
SB 422 requires Montana health insurers to cover FDA-approved drugs for advanced or metastatic cancer without forcing patients to first fail other treatments. It prohibits insurers from demanding that patients prove they've tried and failed alternative drugs before approving coverage for new treatments that align with national cancer guidelines. This directly affects patients diagnosed with advanced or metastatic cancer in Montana, ensuring faster access to potentially life-saving medications without unnecessary bureaucratic hurdles. The law applies only to drugs approved by the FDA and consistent with evidence-based cancer treatment protocols.
HB 198 revises laws that prohibit contracts restricting the practice of specific healthcare providers. The bill prevents employment or professional relationship contracts from limiting a healthcare provider's right to practice their licensed profession in any area or for any period after their relationship ends. It also prohibits contracts from restricting their ability to treat or solicit current patients of their former employer or partner. This applies to a range of providers, including psychiatrists, psychologists, various counselors, nurses, and physician assistants, but does not apply to contracts for the sale of a practice.
HB 885 aims to improve customer service for Medicaid applicants and recipients in Montana. It requires the Department of Public Health and Human Services (DPHHS) to implement mobile-first technology for online applications and renewals, utilize text and email for communications, and ensure written notices are in plain language and translated. The bill also mandates the DPHHS to provide expected wait times and callback options for hotline callers and to reopen 10 local public assistance offices by June 30, 2026. Additionally, it establishes quarterly reporting requirements to the legislature on various Medicaid client service metrics.
House Bill 371 aimed to prohibit the administration of gene-based vaccines, including those using messenger RNA (mRNA) or deoxyribonucleic acid (DNA) technology, to humans within the state of Montana. The bill proposed that anyone providing or administering such a vaccine would be guilty of a misdemeanor, facing a $500 fine for each incident. It also required the relevant licensure board to review the license of any professional who violated this prohibition. This legislation would directly affect healthcare providers and individuals seeking these specific types of vaccines in Montana.
HB 459 would amend Montana law to increase the number of physician assistants on the Board of Medical Examiners from one to two. This change directly affects the composition of the 13-member board, which oversees medical licensing and regulation in Montana. The bill specifically revises Section 2-15-1731 of the Montana Code to add a second physician assistant position to the existing board structure. The bill was introduced in the 2025 legislative session but was withdrawn on February 14, 2025.
House Bill 556 regulates how health insurance issuers use artificial intelligence (AI) for reviewing and managing healthcare services. It prohibits AI, algorithms, or other software tools from solely determining medical necessity or denying, delaying, or modifying healthcare services. Instead, medical necessity determinations must be made by licensed healthcare professionals, considering individual patient history and circumstances, not just group data. The bill also requires AI tools to be applied fairly, avoid discrimination, and be open to audit, making non-compliance an unfair claim settlement practice.
HB 758 aims to protect health benefit plan enrollees from balance billing for out-of-network ground ambulance services. It prohibits ambulance services from billing enrollees more than their in-network cost-sharing for covered transportation. The bill requires insurers to pay ambulance providers directly, caps out-of-pocket costs for these services at $100, and ensures these costs count towards deductibles. It also mandates that insurers reimburse ambulance services at established local rates or at least 400% of the Medicare rate if no contracted rate exists, and requires the state to create a public database of local ambulance rates.
SB 334 would have expanded Montana Medicaid eligibility to able-bodied adults under 65 with incomes at or below 100% of the federal poverty level, but only if they met community engagement requirements. Key provisions include mandating participation in workforce development programs (like job training in healthcare or cybersecurity) and requiring the state to seek federal waiver approval by December 2025. The bill also included measures like biannual eligibility reviews and lifetime benefit limits for this group. However, the bill died in process on May 23, 2025, after failing to advance beyond committee review.
